Company profile for Golden Biotechnology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Golden Biotechnology Corporation (GBC), founded by Mr. Sheng Yung, Liu in 2002, is an leading and innovative drug discovery and evidence-based healthy food supplement manufacturing company dedicated to enhancing lives by developing high quality products that prevent and treat diseases. GBC’s main focus is on new drug R&D, IP right, pharmacology, toxicology and clinical studies. GBC also has successfully built up the scree...
Golden Biotechnology Corporation (GBC), founded by Mr. Sheng Yung, Liu in 2002, is an leading and innovative drug discovery and evidence-based healthy food supplement manufacturing company dedicated to enhancing lives by developing high quality products that prevent and treat diseases. GBC’s main focus is on new drug R&D, IP right, pharmacology, toxicology and clinical studies. GBC also has successfully built up the screening platforms to identify bioactive compounds from traditional Chinese herbal medicine that includes more than 480 kinds of local plants, 1300 species of fungi, mushrooms and seaweeds.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Taiwan
Address
Address
15F, No. 27- 6, Sec.2, Zhongzheng E. Rd.,Tamsui Dist
Telephone
Telephone
+ 886-2-2808-6006
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/asco-gi-2024-golden-biotechs-antroquinonol-shows-significantly-prolonged-survival-in-untreated-metastatic-pancreatic-cancer-patients-302038201.html

PR NEWSWIRE
18 Jan 2024

https://www.prnewswire.com/news-releases/targeting-ras-golden-biotech-announces-positive-results-with-longer-survival-compared-with-standard-treatments-from-interim-analysis-of-phase-2-trial-for-antroquinonol-as-1st-line-treatment-for-stage-4-metastatic-pancreatic-cance-301817006.html

PR NEWSWIRE
05 May 2023

https://www.prnewswire.com/news-releases/covid-19-scoop-epoch-making-goldenbiotechs-oral-covid-19-new-drug-trial-got-green-light-from-the-fda-to-extend-recruiting-severe-covid-19-patients-301378463.html

PRNEWSWIRE
16 Sep 2021

https://www.prnewswire.com/news-releases/covid-19-drug-duo-achievements-goldenbiotechs-new-drug-antroquinonol-hocena-trial-receives-positive-response-from-dmc-review-and-licenses-for-4-countries-301222107.html

PRNNEWSWIRE
04 Feb 2021

https://www.biospectrumasia.com/news/26/16217/golden-biotech-receives-fda-approval-for-covid-19-drug-trial.html

BIOSPECTRUMASIA
02 Jul 2020

https://en.prnasia.com/releases/global/anti-viral-and-anti-inflammatory-response-goldenbiotech-s-antroquinonol-receives-fda-approval-on-covid-19-phase-2-trial-in-usa-284264.shtml

PRNASIA
01 Jul 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty